Investor Flags Antibiotics Co. Melinta's $75M Stock Sale
By Rose Krebs ( December 3, 2018, 8:23 PM EST) -- A stockholder filed a proposed class action in Delaware Chancery Court claiming antibiotics company Melinta Therapeutics Inc.'s board breached its fiduciary duty by entering into an agreement to sell $75 million of the company's stock to shareholder Vatera Holdings LLC at a time when the stock value is distressed....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.